酒精性心肌病:综述更新
本文综述了酒精性心肌病(AC)的发病机制、诊断与治疗进展。AC 是长期大量饮酒导致的获得性扩张型心肌病(DCM),每日酒精摄入量 >80 g 持续 5 年以上通常被认为足以致病。其发病涉及乙醇直接毒性、乙醛介导心肌损伤、遗传易感(尤其 TTN 截短变异)及酒精与高血压或肝硬化等共病的协同作用。戒酒是治疗核心,戒酒者左室射血分数恢复与良好预后相关;其余按射血分数降低心衰指南治疗。
要点
- AC 诊断需长期大量饮酒(通常 >80 g/d 持续 5 年)并排除其他 DCM 病因。
- 发病机制涉及乙醇直接毒性、乙醛心肌损伤、遗传易感(如 TTN 截短变异)及共病协同作用。
- 戒酒是 AC 最关键治疗,戒酒者左室射血分数恢复与极好预后相关;余按 HFrEF 指南治疗。
核心结论
- AC 是长期大量饮酒导致的获得性 DCM,戒酒是治疗最关键步骤,戒酒者左室射血分数恢复与极好预后相关。
- AC 发病支持双重打击假说,即遗传因素与环境因素(酒精)共同作用。
研究设计与样本
- 本文为综述,聚焦 AC 的发病机制、诊断与治疗进展。
主要发现
- 乙醇直接毒性促进心肌氧化应激并激活肾素-血管紧张素系统。
- 乙醛可损害肌动蛋白-肌球蛋白相互作用并导致线粒体功能障碍。
- AC 患者中可发现致 DCM 的遗传变异,尤其是 TTN 截短变异。
- 酒精与高血压或肝硬化等共病的协同作用可促进 AC 发生。
- AC 与其他 DCM 相比无特异性心脏症状和体征,但自然病史不同,直接取决于是否戒酒。
关键数值与推荐
- 产生 AC 所需的酒精量通常被认为 >80 g/d 持续 5 年,但该定义仍存争议。
临床怎么用
- 戒酒是 AC 治疗最关键步骤,已有针对戒酒的特定疗法可用。
- 其余治疗按当前射血分数降低心衰指南进行。
- 针对 AC 发病机制的靶向治疗正在开发中,未来可能改善治疗。
局限性
- AC 的酒精摄入量定义(>80 g/d 持续 5 年)仍存争议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alcohol-induced cardiomyopathy (AC) is an acquired form of dilated cardiomyopathy (DCM) caused by prolonged and heavy alcohol intake in the absence of other causes. The amount of alcohol required to produce AC is generally considered as >80 g/day over 5 years, but there is still some controversy regarding this definition. This review on AC focuses on pathogenesis, which involves different mechanisms. Firstly, the direct toxic effect of ethanol promotes oxidative stress in the myocardium and activation of the renin-angiotensin system. Moreover, acetaldehyde, the best-studied metabolite of alcohol, can contribute to myocardial damage impairing actin-myosin interaction and producing mitochondrial dysfunction. Genetic factors are also involved in the pathogenesis of AC, with DCM-causing genetic variants in patients with AC, especially titin-truncating variants. These findings support a double-hit hypothesis in AC, combining genetics and environmental factors. The synergistic effect of alcohol with concomitant conditions such as hypertension or liver cirrhosis can be another contributing factor leading to AC. There are no specific cardiac signs and symptoms in AC as compared with other forms of DCM. However, natural history of AC differs from DCM and relies directly on alcohol withdrawal, as left ventricular ejection fraction recovery in abstainers is associated with an excellent prognosis. Thus, abstinence from alcohol is the most crucial step in treating AC, and specific therapies are available for this purpose. Otherwise, AC should be treated according to current guidelines of heart failure with reduced ejection fraction. Targeted therapies based on AC pathogenesis are currently being developed and could potentially improve AC treatment in the future.
引用
- Domínguez F, Adler E, García-Pavía P, et al. Alcoholic cardiomyopathy: an update. Eur Heart J. 2024. PMID: 38848133. doi:10.1093/eurheartj/ehae362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。